Paris-based Orakl Oncology has raised an oversubscribed $34 million (€31 million) Series A, co-led by Swedish investor ...
French ADC start-up Adcytherix SAS has added €105m Series A funding to a €30m seed financing round closed last year. With the money, the company will start a Phase I study with its lead ADCX-020 in Q1 ...
Germany-based biotech company SRTD Biotech has closed a €31.5 million seed funding round. At the heart of its approach is an ...
Swiss venture capital investor Redalpine has closed its eighth fund at $250 million. Redalpine Capital VIII reached its hard ...
Nine reports of tumors in children treated with Novartis' spinal muscular atrophy (SMA) gene therapy Zolgensma raise new ...
University of Oxford spinout Alethio Therapeutics has raised $90 million (about €80 million) to take its G6B-targeting ...
Dutch-Belgian immunology company argenx has agreed to acquire California-based Unnatural Products Inc. (UNP) for up to $1.15 ...
The Mainz-based vaccine developer is making progress in its transformation into an oncology company. But its quarterly report ...
Paris-based Orakl Oncology has raised an oversubscribed $34 million (€31 million) Series A, co-led by Swedish investor ...
French pharmaceutical group Servier has suffered a major setback just four months after completing its $1.55 billion upfront acquisition of Edgewise Therapeutics' muscular dystrophy business.
Gene therapies began as proof-of-concept treatments for a handful of rare genetic disorders and now, with emerging tools, may ...
Boehringer is turning to China for cancer research in a multibillion-dollar deal with Sino Biopharmaceutical. Six preclinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results